Tyra Biosciences CEO sells over $283k in company stock
In recent trading activity, Todd Harris, the President and CEO of Tyra Biosciences, Inc. (NASDAQ:TYRA), a company specializing in pharmaceutical preparations, has
In recent trading activity, Todd Harris, the President and CEO of Tyra Biosciences, Inc. (NASDAQ:TYRA), a company specializing in pharmaceutical preparations, has
Executives at PineBridge, a global asset management firm, have sold a significant amount of shares in IBEX Ltd (NASDAQ:IBEX), a company specializing
(Reuters) – Spirit Aerosystems will begin furloughs in three weeks if a strike at its biggest customer Boeing (NYSE:BA) continues, the Financial
Dream Finders Homes, Inc. (NASDAQ:DFH) President and CEO Patrick O. Zalupski has recently sold a significant portion of his holdings in the
ChargePoint (NYSE:CHPT) Holdings, Inc. (NYSE:CHPT), a leader in electric vehicle charging infrastructure, has reported a notable stock transaction by its President and
In a recent transaction, Parker Harris, the Co-Founder and Chief Technology Officer of Slack, a Salesforce, Inc. (NYSE:CRM) subsidiary, sold a significant
In a recent transaction, Dr. Lindsay (NYSE:LNN) A. Rosenwald, President, CEO, and Chairman of Fortress Biotech, Inc. (NASDAQ:FBIO), has made a significant
In a recent transaction on September 23, Michael Hogan, a director at American Coastal Insurance Corp (OTCMKTS:ACIC), acquired shares of the company’s
Nuvalent, Inc. (NASDAQ:NUVL) Director Matthew Shair has recently sold a portion of his holdings in the company, according to the latest filings.
Cyanotech Corporation (NASDAQ:CYAN) director Michael A. Davis has acquired additional shares of the company, according to a recent SEC filing. The transactions,